4-SEC-BUTYLANILINE
| Price | $1 |
| Package | 1KG |
| Min. Order: | 1KG |
| Supply Ability: | 100KG |
| Update Time: | 2020-01-09 |
Product Details
| Product Name: 4-SEC-BUTYLANILINE | CAS No.: 30273-11-1 |
| EC-No.: 250-108-9 | Min. Order: 1KG |
| Purity: 99% | Supply Ability: 100KG |
| Release date: 2020/01/09 |
Sophia 1056 Email: sophia@coreychem.com
▼
▲
4-SEC-BUTYLANILINE Basic information
▼
▲
Product Name:
4-SEC-BUTYLANILINE
Synonyms:
4-sec-butylbenzenamine;4-sec-Butylaniline;4-SEC-BUTYLANILINE;4-(2-BUTYL)ANILINE;AKOS BBS-00003701;4-(1-methylpropyl)-benzenamin;4-(1-methylpropyl)-Benzenamine;4-Amino-sec-butylbenzene
CAS:
30273-11-1
MF:
C10H15N
MW:
149.23
EINECS:
250-108-9
Product Categories:
Mol File:
30273-11-1.mol
▼
▲
4-SEC-BUTYLANILINE Chemical Properties
▼
▲
Melting point
1.08°C (estimate)
Boiling point
244-245 °C727 mm Hg(lit.)
density
0.977 g/mL at 25 °C(lit.)
refractive index
n20/D 1.537(lit.)
Fp
226 °F
pka
5.02±0.10(Predicted)
CAS DataBase Reference
30273-11-1(CAS DataBase Reference)
EPA Substance Registry System
Benzenamine, 4-(1-methylpropyl)- (30273-11-1)
▼
▲
Safety Information
▼
▲
Hazard Codes
Xi
Risk Statements
36/37/38
Safety Statements
26-36
RIDADR
2810
WGK Germany
3
HazardClass
IRRITANT
PackingGroup
III
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates：
Pharmaceutical intermediates;
OLED intermediates;
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2024-07-25 | |
| $0.00/25KG |
VIP1Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2024-11-08 | |
| $1.00/1PCS |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-11-05 | |
| $30.00/1KG |
VIP3Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-10-29 |
China- Since: 2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY